Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Change in Cash (2023 - 2025)

Historic Change in Cash for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to $36.2 million.

  • Camp4 Therapeutics' Change in Cash rose 45919.24% to $36.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.7 million, marking a year-over-year increase of 25170.1%. This contributed to the annual value of $25.7 million for FY2024, which is 15761.92% up from last year.
  • Per Camp4 Therapeutics' latest filing, its Change in Cash stood at $36.2 million for Q3 2025, which was up 45919.24% from -$10.3 million recorded in Q2 2025.
  • In the past 5 years, Camp4 Therapeutics' Change in Cash ranged from a high of $61.5 million in Q4 2024 and a low of -$14.7 million during Q1 2025
  • Moreover, its 3-year median value for Change in Cash was -$10.8 million (2024), whereas its average is $3.1 million.
  • In the last 5 years, Camp4 Therapeutics' Change in Cash skyrocketed by 60881.79% in 2024 and then tumbled by 2954.23% in 2025.
  • Camp4 Therapeutics' Change in Cash (Quarter) stood at -$12.1 million in 2023, then soared by 608.82% to $61.5 million in 2024, then tumbled by 41.14% to $36.2 million in 2025.
  • Its last three reported values are $36.2 million in Q3 2025, -$10.3 million for Q2 2025, and -$14.7 million during Q1 2025.